Concepedia

Raji Swamy

RS

Statistics

Publications

9

Citations

639

H-Index

9

Active since

1984

Affiliations

Defence Research and Development Establishment(Current)

Raji Swamy is an author at Defence Research and Development Establishment specializing in insect repellents, pharmacology, and entomology.

Publications per year

1984–2017

9

Publications

9

RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

Adam Brufsky, Sara A. Hurvitz, Edith A. Perez et al. · Journal of Clinical Oncology · 2011 · 419 citations · Full text

Medicine, Oncology, Pharmacology +17

RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab In Combination with Chemotherapy for Second-Line Treatment of HER2-Negative Metastatic Breast Cancer.

Adam Brufsky, Igor Bondarenko, V. Yu. Smirnov et al. · Cancer Research · 2009 · 67 citations

Medicine, Oncology, Pharmacology +14

Structure-Activity Relationship Studies with Mosquito Repellent Amides

M. V. Suryanarayana, Karuna Shanker Pandey, Shri Prakash et al. · Journal of Pharmaceutical Sciences · 1991 · 48 citations

Pharmacy, Entomology, Medicinal Chemistry +14

Field evaluation of three repellents against mosquitoes, black flies & land leeches.

Sanmugapriya Nagul Kumar, Shiroman Prakash, R K Sharma et al. · PubMed · 1984 · 26 citations

Life Sciences, Entomology, Insect Behavior +12

Progression-free survival (PFS) in patient subgroups in RIBBON-2, a phase III trial of chemotherapy (chemo) plus or minus bevacizumab (BV) for second-line treatment of HER2-negative, locally recurrent or metastatic breast cancer (MBC).

Adam Brufsky, Ragene Rivera, SA Hurvitz et al. · Journal of Clinical Oncology · 2010 · 25 citations

Medicine, Oncology, Pharmacology +10

1–5 of 9